Experimental determination of dosimetric characteristics of Best® 125I brachytherapy source

Medical Physics

Volumn 27, Issue 9, 2000, Pages 2168-2173

  Meigooni, Ali S ^a   Gearheart, Darren M ^a   Sowards, Keith ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

125I; Brachytherapy; Dosimetry; Thermoluminescent dosimeter

Indexed keywords

ANISOTROPY; DOSIMETERS; LITHIUM COMPOUNDS; ONCOLOGY; RADIOTHERAPY; RATE CONSTANTS;

ANISOTROPY CONSTANTS; BRACHYTHERAPY; DOSIMETRIC PARAMETER; EXPERIMENTAL DETERMINATION; INTERSTITIAL BRACHYTHERAPY; RADIAL DOSE FUNCTION; THERMOLUMINESCENT DOSIMETERS; ^125I;

DOSIMETRY;

IODINE 125;

ANISOTROPY; ARTICLE; BRACHYTHERAPY; DEVICE; DOSE RESPONSE; DOSIMETRY; HUMAN; MEASUREMENT; PRIORITY JOURNAL; PROSTATE TUMOR; RADIATION DOSE DISTRIBUTION;

EID: 0033805914     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.1289256     Document Type: Article

References (14)

1. K. J. Russell and J. C. Blasko, "Recent advances in interstitial brachytherapy for localized prostate cancer," Probl. Urolo. 7, 260-278 (1993).
2. D. Nori, "Conformal brachytherapy of prostate cancer: An effective outpatient treatment," Cancer Watch 1, 124-126 (1992).
3. M. S. Porrazzo, B. S. Hilaris, C. R. Moorthy, A. E. Tchelebi, C. A. Mastoras, L. L. Shih, L. Stabile, and N. Salvaras, "Permanent interstitial implantation using palladium-103: The New York Medical College preliminary experience," Int. J. Radiat. Oncol., Biol., Phys. 23, 1033-1036 (1992).
4. 125I implantation for Stage T1/T2 Prostate carcinoma," J. Urol. (Baltimore) 154, 1096-1099 (1995).
5. 125I source for interstitial brachytherapy," Med. Phys. 20, 1475-1483 (1993).
6. R. Nath, L. L. Anderson, G. Luxton, K. A. Weaver. J. F. Williamson, and A. S. Meigooni, "Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43," Med. Phys. 22, 109-234 (1995).
7. A. S. Meigooni, J. F. Williamson, and R. Nath, "Single source dosimetry for interstitial brachytherapy," Brachytherapy Physics, edited by J. F. Williamson, B. R. Thomadson, and R. Nath (Medical Physics Publishing, Madison, WI, 1995), Chap. 10, pp. 210-233.
8. 125I interstitial sources: Dosimetry and calibration changes," Med. Phys. 26, 570-573 (1999).
9. J. F. Williamson, B. M. Coursey, L. A. DeWerd, W. F. Hanson, R. Nath, and G. S. Ibbott, "Dosimetric prerequisites for routine clinical use of new low energy photon interstitial brachytherapy sources," Med. Phys. 25, 2269-2278 (1998).
10. A. S. Meigooni, V. Mishra, H. Panth, and J. F. Williamson, "Instrumentation and dosimeter-size artifacts in quantitative thermoluminescence dosimetry of low-dose fields," Med. Phys. 22, 555-561 (1995).
11. P. J. Muench, A. S. Meigooni, R. Nath, and W. L. McLaughlin, "Photon energy dependence of the sensitivity of radiochromic film and comparison with silver halide film and LiF TLDs used for brachytherapy dosimetry," Med. Phys. 18, 769-775 (1991).
12. 192Ir Seeds," Med. Phys. 18(4), 776-785 (1991).
13. 125I brachytherapy source," Med. Phys. 26, 1925-1931 (1999).
14. 103Pd sources." Med. Phys. 25, 2271-2278 (1998).